📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD-mutant AML. (2021)

First Author: Pacharne S

Attributed to: Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’ funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2020003443

PubMed Identifier: 33956058

Publication URI: http://europepmc.org/abstract/MED/33956058

Type: Journal Article/Review

Volume: 5

Parent Publication: Blood advances

Issue: 9

ISSN: 2473-9529